The COVID-19 pandemic has rapidly transformed the clinical trials landscape. What is happening to data as clinical trials become increasingly decentralized? Join Darshan Kulkarni as he talks with guests Craig Lipset, Artem Andrianov and Moe Alsumidaie about the new role of data in clinical trials. Plus, we’ll discuss the advantages of risk based monitoring.
A discussion with CRO CEO John Reites. Our discussion will explore decentralized clinical trials, the missing secret ingredient in clinical...
A discussion with health and clinical trial entrepreneur Zedrick Buhay on starting a clinical trial site, choosing studies and therapeutic...
A discussion on Project Management/Clinical Monitoring/Clinical Operations including on Clinical Development Training, recruitment and...
